If you could vote on Brexit now which option would you choose?
   

Novavax publishes positive initial data for first combined Covid and flu vaccine


Novavax has published the first clinical data for a combined Covid-19 and flu vaccine, with promising initial findings that a two-in-one shot could be safe and effective. The trial, conducted in Australia, studied the combined shot in almost 650 people aged 50 to 70. An initial analysis found that their immune responses were similar to that for Novavax’s standalone Covid-19 vaccine and its flu vaccine candidate, which is waiting for regulatory approval. The safety profile was also similar to the individual vaccines, with no serious adverse events.

Financial Times - April 21, 2022

View the full story here: https://www.ft.com/content/bf129ee9-e5f6-435d-9b0c-7c0a1c3f3e47